144
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Validation of the Inflammatory Bowel Disease Questionnaire in Swedish Patients with Ulcerative Colitis

Pages 77-85 | Published online: 08 Jul 2009

References

  • Garrett JW, Drossmann DA. Health status in inflammatory bowel disease. Biological and behavioral considerations. Gastroenterology 1990;99:240–6.
  • Hjortswang H, Almer S, Ström M. The network: a strategy to describe the relationship between quality of life and disease activity. The case of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:1099–104.
  • Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, et al. Quality of life: a valid and reliable measure of the therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology 1994;106:287–96.
  • Hjortswang H, Ström M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol 1998;93:2203–11.
  • Drossman DA, Leserman J, Li Z, Mitchell CM, Zagmani EA, Patrick DL. The Rating Form of IBD Patient Concerns: a new measure of health status. Psychosom Med 1991;53:701–12.
  • Hjortswang H, Ström M, Almeida RT, Almer S. Evaluation of the RFIPC, a disease-specifi c health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol 1997;32:1235–40.
  • Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–81.
  • McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31: 247–63.
  • Sullivan M, Karlsson J, Ware JE SF-36 Hälsoenkät: svensk manual och tolkningsguide [Swedish manual and interpretation guide]. Gothenburg: Sahlgrenska University Hospital; 1994.
  • Sullivan M, Karlsson J. The Swedish SF-36 health survey. III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998;51: 1105–13.
  • Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. USA: Le Jacq Publishing; 1984. p. 170–83.
  • Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials: selecting quality of life measures. Control Clin Trials 1991;12:S204–16.
  • Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ 1964;1:89–96.
  • Ginsberg AL, Beck LS, McIntosh TM, Nochomowitz LE. Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial. Ann Intern Med 1988;108:195–9.
  • Marquis P, Fayol C, Joire JE, Leplège A. Psychometric properties of a specific quality of life questionnaire in angina pectoris patients. Qual Life Res 1995;4:540–6.
  • Lopez-Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada JR. Validation of the Spanish version of the Inflammatory Bowel Disease Questionnaire on ulcerative colitis and Crohn’s disease. Digestion 1999;60:274–80.
  • Russel M, Pastoor CJ, Brandon S, Rijken J, Engels L, van der Heijde D, et al. Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion 1997;58:282–8.
  • De Boer A, Wijker W, Bartelsman J, de Haes H. Inflammatory Bowel Disease Questionnaire: cross-cultural adaptation and further validation. Eur J Gastroenterol Hepatol 1995;7:1043–50.
  • Han SW, McColl E, Steen N, Barton JR, Welfare MR. The Inflammatory Bowel Disease Questionnaire: a valid and reliable measure in ulcerative colitis patients in the North East of England. Scand J Gastroenterol 1998;33:961–6.
  • Irvine EJ. Development and subsequent refinement of the Inflammatory Bowel Disease Questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999;28:S23–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.